Welcome to our dedicated page for Masimo SEC filings (Ticker: MASI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Masimo’s dual focus on noninvasive patient-monitoring sensors and high-fidelity consumer audio means its SEC disclosures span everything from hospital connectivity contracts to headphone royalty agreements. Digging through the 300-page 10-K to pinpoint segment revenue or R&D spend can feel impossible—and that’s before you chase down Form 4 trades by clinicians on the advisory board.
Our platform solves that problem. Stock Titan delivers AI-powered summaries that turn complicated language into clear insight, so understanding Masimo SEC documents with AI becomes routine. Need the latest Masimo quarterly earnings report 10-Q filing? It’s indexed alongside an AI synopsis of sensor-unit growth. Want alerts on Masimo insider trading Form 4 transactions? You’ll receive Masimo Form 4 insider transactions real-time, complete with context. Even the dense Masimo proxy statement executive compensation is broken down to show incentive metrics tied to patient-safety outcomes.
Here’s what investors routinely monitor:
- Masimo annual report 10-K simplified—segment margins, patent litigation, and hospital adoption data.
- Masimo 8-K material events explained—FDA clearances, supply-chain updates, or audio-brand launches.
- Masimo executive stock transactions Form 4—track insider sentiment before product releases.
- Masimo earnings report filing analysis—AI extracts cash-flow trends and sensor ASP changes.
With real-time EDGAR feeds, comprehensive coverage of every form, and expert commentary, Masimo SEC filings explained simply are finally within reach—saving hours and sharpening decisions.
Masimo Corporation reported third‑quarter results reflecting solid performance in healthcare operations and the completion of its consumer audio divestiture. Total revenue was
Masimo closed the Sound United sale on September 23, 2025. On the balance sheet, cash and cash equivalents increased to
Masimo Corporation furnished an 8‑K announcing it issued a press release with financial results for the quarter ended September 27, 2025, and provided a supplemental investor presentation. The press release (Exhibit 99.1) and supplemental materials (Exhibit 99.2) are furnished under Items 2.02 and 7.01 and are not deemed “filed” for Section 18 liability or incorporated by reference unless expressly stated.
The CFO planned to review third‑quarter 2025 results and an updated outlook for the remainder of fiscal 2025 on a conference call scheduled for November 4, 2025.
Masimo Corporation (MASI) insider sale notice: This Form 144 shows that 25,061 shares of Masimo common stock are proposed to be sold via Charles Schwab & Co., Inc. on 09/29/2025 with an aggregate market value of $3,553,637. The shares were acquired and paid on 09/29/2025 through an employee stock option exercise using a broker cashless exercise. The filing reports total shares outstanding of 54,324,812. The seller, identified in prior sales as Bilal Muhsin, sold 25,000 shares on 09/23/2025 for $3,518,983 and 50,000 shares on 09/26/2025 for $7,093,910. By combining the prior sales and the proposed sale, the filing documents insider dispositions totaling 100,061 shares during late September 2025. The filer certifies no undisclosed material adverse information and includes the standard Rule 144 representations.
Form 144 notice for MASIMO CORP (MASI) indicates a proposed sale of 50,000 common shares acquired and to be sold on 09/26/2025 following an employee stock option exercise. The broker listed is Charles Schwab & Co., Inc. with an aggregate market value of $7,093,910.00 and the issuer's shares outstanding reported as 54,324,812. The filing shows a prior sale by the same person on 09/23/2025 of 25,000 shares for gross proceeds of $3,518,983.00. The filer certifies they are unaware of undisclosed material adverse information.
Tripodi Blair, Chief Operating Officer, Consumer Division of Masimo Corporation (MASI), reported transactions on Form 4 dated 09/23/2025. On that date 15,000 restricted stock units (granted March 1, 2024) were treated as acquired/settled using a $142.13 per-share price, and 8,078 shares were withheld to satisfy tax withholding. After these transactions the filing shows beneficial ownership figures of 21,896 and 13,818 shares for the reported classes. The filing states the RSUs fully accelerated on 09/23/2025 because Mr. Tripodi resigned for "good reason" in connection with the Company’s sale of its consumer audio business.
Form 144 filed for MASIMO CORPORATION (MASI): An individual proposes selling 25,000 common shares acquired the same day via an employee stock option exercise. The filing lists an aggregate market value of $3,518,983.00 and identifies Charles Schwab & Co., Inc. as the broker. The planned sale date is 09/23/2025 on NASDAQ.
The filing states the payment was handled by the broker as a cashless exercise. The filer reports no securities sold in the past three months and affirms they are not aware of undisclosed material adverse information about the issuer.
Charles Dadswell, a director of Masimo Corporation (MASI), reported equity awards granted on August 18, 2025. The filing shows 2,273 restricted stock units (RSUs), each representing a contingent right to one share, and a non-qualified stock option covering 5,104 shares with an exercise price of $153.93. The RSUs vest ratably over four years with 25% vesting on each anniversary of the grant date. The option vests over five years with 20% vesting on each anniversary and is exercisable as it vests.
The Form 4 was filed individually and signed by an attorney-in-fact on behalf of the reporting person. All information in this summary is taken directly from the Form 4 content.
FAQ
What is the current stock price of Masimo (MASI)?
What is the market cap of Masimo (MASI)?
